← Every company

Humacyte Inc SEC Filings

What Humacyte Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

HUMA overview →
Filings on file
81
since Aug 4, 2020
Warning signs
4
latest Jul 31, 2026
Last results
Aug 12, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 12, 2026
Results announced
8-K
Read ↗
Mar 19, 2026
Results announced
8-K
Read ↗
Nov 12, 2025
Results announced
8-K
Read ↗
Aug 11, 2025
Results announced
8-K
Read ↗
May 13, 2025
Results announced
8-K
Read ↗
Mar 28, 2025
Results announced
8-K
Read ↗
Nov 8, 2024
Results announced
8-K
Read ↗
Aug 13, 2024
Results announced
8-K
Read ↗
May 10, 2024
Results announced
8-K
Read ↗
Mar 22, 2024
Results announced
8-K
Read ↗
Nov 9, 2023
Results announced
8-K
Read ↗
Aug 14, 2023
Results announced
8-K
Read ↗
May 12, 2023
Results announced
8-K
Read ↗
Mar 24, 2023
Results announced
8-K
Read ↗
Nov 10, 2022
Results announced
8-K
Read ↗
Aug 12, 2022
Results announced
8-K
Read ↗
May 13, 2022
Results announced
8-K
Read ↗
Mar 29, 2022
Results announced
8-K
Read ↗
Nov 12, 2021
Results announced
8-K
Read ↗

Source: Humacyte Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on HUMA

Related datasets